... investigation. The original treatment, called intravenous immunoglobulin or IVIG, is an amalgam of specific antibodies made from the pooled blood plasma of thousands of healthy donors. Physicians have ...
... a few tablespoons of blood, we can now rapidly generate human monoclonal antibodies that potentially could be used for diagnosis and treatment of newly emerging strains of influenza,” says Dr. Wilson. ...
... future pandemics. Researchers report in Nature today that they have perfected a way to manufacture monoclonal antibodies capable of destroying diseases such the avian flu, which have the ability to ...
... over the last decade seem to have contributed to a decline in prevalence of anti-HAV antibodies. However, the authors observed that the majority of their beta-thalassemia patients were anti-HAV-IgG- ...
Each of us carries an unbelievable multitude of antibodies, allowing us to survive the daily battle against pathogens. However, sometimes these antibodies go haywire and attack structures of their own ...
... to at least 160 million years ago and by looking at the differences between the ancient and the modern antibodies we can begin to understand how to design better drugs to stop allergic reactions in ...
... -8 in genomic DNA was investigated in 22 of the participants at clinical onset of diabetes.
HHV-8 antibodies were found in 71 patients (87.7 percent) with ketosis-prone DM-2 vs. 16 patients (15.1 ...
Scientists have created a 'library' of shark antibodies that have been modified to target certain diseases, such as malaria, and could lead to new treatments.
Antibodies are recycled for a second important role, amplifying immune responses so they can react to threats in tiny quantities, researchers have found.
... a common inflammatory protein, IL-8. When the scientists blocked the protein in mice with an antibody, they found that it completely halted the spread of breast cancer to the lungs.
In addition, ...
Antibodies are proteins that are a crucial component of the immune system. They are produced in large amounts by immune cells known as plasma cells, which live in just a few parts of the body, ...
A chemist has discovered a new marker together with three associated monoclonal antibodies which are promising candidates for cancer therapy. Up to now, monoclonal antibodies have only aided the ...
Controlled drug attachment to antibodies lowers side-effects of cancer treatment
... a physiologically relevant and standardized platform for reproducible measurement of neutralizing antibodies. Until such a product is available, researchers recommend that parallel evaluation with ...
... Reuters) - GlaxoSmithKline Plc's head of biotech research is excited about a new generation of "slimline" antibody medicines that may be successors to current blockbusters such as Avastin and Rituxan.
